Skip to main content

and
  1. No Access

    Article

    Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study

    The unfavorable effect of proton pump inhibitors (PPIs) on cardiovascular (CV) outcomes and mortality was reported in the general population. We investigated the impact of PPIs on CV outcomes and total mortali...

    Andreana Foresta, Luisa Ojeda Fernandez, Ginevra Torrigiani, Simone Schena in Drugs & Aging (2024)

  2. Article

    Open Access

    Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction

    Diabetes mellitus (DM) is associated with an increased mortality risk in patients hospitalized with acute myocardial infarction (AMI); however, no studies have investigated the impact of the duration of DM on ...

    Marta Baviera, Stefano Genovese, Pierluca Colacioppo in Cardiovascular Diabetology (2022)

  3. Article

    Open Access

    Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study

    GLP-1 receptor agonists (GLP-1 RA) and SGLT-2 inhibitors (SGLT-2i) have shown to reduce the risk of major adverse cardiovascular events (MACE), death and worsening nephropathy when added to standard of care. H...

    Marta Baviera, Andreana Foresta, Pierluca Colacioppo in Cardiovascular Diabetology (2022)